Virgilio Deloy Capobian Gibbon Sells 800 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 800 shares of the stock in a transaction dated Thursday, March 26th. The stock was sold at an average price of $15.21, for a total transaction of $12,168.00. Following the transaction, the chief executive officer directly owned 153,748 shares in the company, valued at $2,338,507.08. The trade was a 0.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The stock was sold at an average price of $15.18, for a total transaction of $59,202.00.

Afya Stock Performance

Shares of NASDAQ AFYA opened at $14.75 on Monday. The stock has a market capitalization of $1.38 billion, a P/E ratio of 10.10, a P/E/G ratio of 0.66 and a beta of 0.52. Afya Limited has a 52-week low of $13.00 and a 52-week high of $19.90. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21. The firm’s 50-day moving average price is $14.39 and its two-hundred day moving average price is $14.74.

Afya (NASDAQ:AFYA) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.05. Afya had a return on equity of 18.77% and a net margin of 20.31%.The business had revenue of $147.08 million during the quarter, compared to analyst estimates of $174.74 million. As a group, sell-side analysts forecast that Afya Limited will post 1.52 earnings per share for the current year.

Afya Dividend Announcement

The company also recently announced an annual dividend, which will be paid on Monday, April 6th. Investors of record on Wednesday, March 25th will be paid a dividend of $0.656 per share. The ex-dividend date of this dividend is Wednesday, March 25th. This represents a yield of 433.0%. Afya’s dividend payout ratio (DPR) is currently 45.21%.

Analysts Set New Price Targets

AFYA has been the subject of several research reports. Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a research report on Monday, March 9th. UBS Group reissued a “neutral” rating and set a $16.00 target price (down from $18.00) on shares of Afya in a research note on Friday, January 16th. Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a report on Friday, January 16th. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Finally, Wall Street Zen upgraded Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 14th. One investment analyst has rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.30.

Institutional Trading of Afya

A number of hedge funds have recently modified their holdings of AFYA. Daiwa Securities Group Inc. purchased a new position in shares of Afya during the fourth quarter valued at $43,000. Militia Capital Partners LP purchased a new stake in Afya in the 2nd quarter worth about $71,000. Quantbot Technologies LP acquired a new stake in Afya during the 2nd quarter worth about $117,000. Van ECK Associates Corp grew its stake in Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after acquiring an additional 1,377 shares in the last quarter. Finally, State of Wyoming purchased a new position in Afya during the 2nd quarter valued at about $164,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.